A combination messenger RNA vaccine against COVID-19 and seasonal influenza stacked up well against currently recommended vaccines in a phase 3 trial, according to findings published in JAMA.

A new vaccine developed by Moderna aims to protect against both flu and COVID-19 with just one shot. Early studies suggest ...

A new vaccine that combines flu and COVID-19 protection in one shot shows promising results, but the U.S. Food and Drug ...

(Gray News) - A combination shot for flu and COVID-19 using messenger RNA-generated antibodies in a study, but U.S. government regulators want to see data on whether the new vaccine protects people ...

Moderna also hopes that combining the shots will help improve vaccine rates. Poland, however, is not sure people will like ...

Virginia localities are preparing to move into phase 1C as more vaccines become available to more of the population. One of ...

State health officials announced Friday those with weakened immune systems can received a third vaccine dose to strengthen ...

In a study published in the Journal of the American Medical Association, researchers from Moderna reported that the new combo ...

Moderna’s study, involving 8,000 adults 50 and older, showed the new combo shot generated an immune response against COVID and most strains of flu compared to existing stand-alone shots.

Kennedy Jr pledged last week that his department will now require all new vaccines to be tested in placebo-controlled trials ...